Institute for Complementary and Integrative Medicine, University Hospital Zurich, Switzerland and University of Zurich, Switzerland.
Hirschmatt Apotheke, Hirschmattstr. 46, 6003 Lucerne, Switzerland.
J Ethnopharmacol. 2019 Mar 1;231:295-301. doi: 10.1016/j.jep.2018.11.022. Epub 2018 Nov 14.
Passiflora incarnata Linnaeus (Passiflora incarnata) was established as a medicinal plant in Europe in the middle of the 19th century. Since then, it has been used for the treatment of anxiety, sleep disorders and restlessness in Western European phytotherapy. This study provides insights into how Passiflora incarnata is currently used and experienced as a medicinal plant by German-speaking patients in Switzerland.
This qualitative study aimed to explore patients' experiences and the values, views and interpretive processes that formed their perceptions of the use of an ethanolic extract of Passiflora incarnata.
A total of 8 patients participated in this exploratory, qualitative observational study. The patients filled in pre- and posttreatment questionnaires, kept diaries and were interviewed in a face-to-face setting. For the data analysis, descriptive statistics, qualitative content analysis, narrative inquiry and documentary methods were applied.
This is the first qualitative study of patients' real-life experiences with an ethanolic extract of Passiflora incarnata. We identified three distinct types of patient biographical narratives attributed to different experiences when using Passiflora incarnata. Patients with type 1 narratives described moving from a performance orientation to resetting priorities and attaining calmness. Patients with type 2 narratives maintained a performance orientation while adopting calmness. Patients with type 3 narratives maintained a performance orientation and suffered from persistent illness.
The distinct biographical narratives of the patients associated with their specific experiences of taking Passiflora incarnata provide an additional perspective on the use of Passiflora incarnata as a medicinal plant.
Passiflora incarnata Linnaeus（西番莲）于 19 世纪中叶在欧洲被确立为药用植物。从那时起，它就一直被用于治疗西欧植物疗法中的焦虑、睡眠障碍和不安。本研究深入了解了德国裔瑞士患者目前如何将 Passiflora incarnata 用作药用植物，以及他们的使用经验和体验。
这项定性研究旨在探索患者的经验以及形成他们对使用西番莲醇提物的看法的价值观、观点和解释过程。
共有 8 名患者参加了这项探索性、定性观察研究。患者填写了治疗前后的问卷、写日记，并在面对面的环境中接受访谈。对于数据分析，采用了描述性统计、定性内容分析、叙事探究和文献方法。
这是第一项关于患者使用西番莲醇提物的真实体验的定性研究。我们确定了三种不同类型的患者传记叙述，这些叙述归因于使用西番莲时不同的体验。第 1 种叙述类型的患者描述了从表现导向到重新设定优先级和获得平静的转变。第 2 种叙述类型的患者保持表现导向，同时采用平静。第 3 种叙述类型的患者保持表现导向并患有持续性疾病。
患者的独特传记叙述与他们服用西番莲的特定体验相关联，为西番莲作为药用植物的使用提供了另一个视角。
